Related Experiment Video
Updated: Apr 29, 2026
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
[Actual diagnosis, treatment and prevention of human granulocytic anaplasmosis]
Abstract:
Ixodes ricinus tick is widely known as a reservoir and vector for many dangerous pathogens. One of them is gram-negative bacteria called Anaplasma phagocytophilum, that may cause human granulocytic anaplasmosis (formerly called granulocytic ehrlichiosis). Development of modem diagnostics, which allows the implementation of effective pharmacotherapy, caused that this disease can be effectively detected only for last couple years. Human granulocytic anaplasmosis in most cases is not a severe ailment, but in some patients, especially improperly diagnosed and treated, it can lead to serious complications or even death. Due to non-specific clinical symptoms and a small number of laboratories proceeding specialized tests, human granulocytic anaplasmosis constitutes clinical and diagnostic problem. A significant increase in tick-borne diseases needs to increase public and physicians awareness of these issues.
Insights
Human granulocytic anaplasmosis, a tick-borne illness caused by Anaplasma phagocytophilum, is increasingly detected due to advanced diagnostics. Early diagnosis and treatment are crucial to prevent severe complications.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Context:
- Ixodes ricinus ticks are significant reservoirs and vectors for pathogens.
- Anaplasma phagocytophilum is a gram-negative bacterium transmitted by ticks.
- Human granulocytic anaplasmosis (HGA) is an emerging tick-borne disease.
Purpose:
- To highlight the diagnostic challenges and clinical significance of HGA.
- To emphasize the importance of increased awareness among physicians and the public regarding tick-borne diseases.
Summary:
- Recent advancements in diagnostics have improved the detection of Anaplasma phagocytophilum, the causative agent of HGA.
- While often not severe, HGA can lead to serious complications or death if misdiagnosed or inadequately treated.
- Non-specific symptoms and limited specialized testing facilities present diagnostic hurdles for HGA.
Impact:
- Enhanced diagnostic capabilities enable timely and effective pharmacotherapy for HGA.
- Increased awareness is vital to address the rising incidence of tick-borne illnesses.
- Prompt diagnosis and treatment are essential to mitigate the risk of severe outcomes and mortality associated with HGA.
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:27Cytomegalovirus Disease